FIELD: chemical-pharmaceutical industry.
SUBSTANCE: present invention relates to the development of a novel fluorescent diagnostic agent with structural formula (1) and a method for production thereof.
EFFECT: high level of selectivity of accumulation of the diagnostic agent in tumor cells, as well as high level of fluorescent contrast of tumor cells during fluorescent diagnostics.
6 cl, 2 dwg, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PHOTOSENSITISER AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2772691C1 |
PREPARATION FOR PHOTODYNAMIC THERAPY AND METHOD FOR PHOTODYNAMIC THERAPY OF CANCER WITH USING IT | 2012 |
|
RU2521327C1 |
NOVEL METHOD AND APPLICATION OF UNSYMMETRICALLY MESO-SUBSTITUTED PORPHYRINS AND CHLORINES FOR PDT | 2009 |
|
RU2574062C9 |
CONJUGATE OF PHOTOSENSITISER AND CHITOSAN AND USES THEREOF | 2013 |
|
RU2675830C2 |
PHOTOSENSITIZER FOR PHOTODYNAMIC THERAPY OF PROSTATE CANCER AND METHOD FR MANUFACTURING THEREOF | 2018 |
|
RU2670087C1 |
AMINO AMIDES IN BACTERIOCHLOROPHYLL A SERIES, HAVING PHOTODYNAMIC ACTIVITY AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2548675C9 |
TREATING OR PREVENTING PROLIFERATIVE CONDITIONS | 2010 |
|
RU2705548C2 |
SULFOXONIUM YLIDE DERIVATIVES AS PROBES FOR CYSTEINE PROTEASE | 2019 |
|
RU2815018C2 |
NAPHTYLENE DERIVATIVE AS CYTOCHROME P450 INHIBITORS | 2004 |
|
RU2363696C2 |
CONJUGATE OF NANOPARTICLES OF GOLD-MAGNETITE COMPOSITION WITH FUNCTIONAL MOLECULE (OPTIONS) AND METHOD OF USE (OPTIONS) | 2023 |
|
RU2811020C1 |
Authors
Dates
2024-07-03—Published
2023-12-13—Filed